PatientsVille.com Logo

PatientsVille

Rasagiline Side Effects

Common Rasagiline Side Effects


The most commonly reported Rasagiline side effects (click to view or check a box to report):

Anaemia (4)
Oedema Peripheral (4)
Asthenia (4)
Serotonin Syndrome (3)
Squamous Cell Carcinoma (2)
Neuroleptic Malignant Syndrome (2)
Confusional State (2)
Aggression (2)
Blood Creatine Phosphokinase Increased (1)
Suicidal Ideation (1)
Blood Pressure Inadequately Controlled (1)
Cognitive Disorder (1)
Tardive Dyskinesia (1)
Laryngeal Cancer (1)
Activities Of Daily Living Impaired (1)
Hallucination, Visual (1)
Convulsion (1)
Death (1)
Delusion (1)
Apathy (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Rasagiline Side Effects Reported to FDA

The following Rasagiline reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Rasagiline on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Serotonin Syndrome
This is a report of a 66-year-old female patient (weight: NA) from ES, suffering from the following symptoms/conditions: parkinson^s disease, who was treated with Rasagiline (dosage: 1 Mg/day, start time: NS), combined with:
  • Stalevo (2 X 150 Tablets/day)
  • Stalevo (4 X 200 Tablets/day)
  • Carbidopa + Levodopa (Tablet At Night)
  • Amantadine (2 X 100mg Tablets/day)
  • Duloxetine (90 Mg/day)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Serotonin Syndrome
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Rasagiline treatment in female patients, resulting in serotonin syndrome side effect.

Papillary Thyroid Cancer
This report suggests a potential Rasagiline Mesylate Papillary Thyroid Cancer side effect(s) that can have serious consequences. A 58-year-old female patient (weight: NA) from IL was diagnosed with the following symptoms/conditions: parkinson^s disease and used Rasagiline Mesylate (dosage: 1 Milligram Daily; Ol Phase) starting 2012. Soon after starting Rasagiline Mesylate the patient began experiencing various side effects, including:
  • Papillary Thyroid Cancer
Drugs used concurrently: NA.The patient was hospitalized. Although Rasagiline Mesylate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as papillary thyroid cancer, may still occur.

Parkinson^s Disease
This Parkinson^s Disease problem was reported by a physician from CN. A 56-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: parkinson^s disease. On 2011 this consumer started treatment with Rasagiline Mesilate (dosage: NA). The following drugs were being taken at the same time:
  • Madopar (1st Dose)
  • Sinemet (1st Dose)
  • Sinemet (2nd Dose)
  • Sinemet (3rd Dose)
  • Sinemet (1st Dose)
  • Entacapone (200 Milligram Daily;)
  • Piribedil Sustained Release Tablets (150 Milligram Daily;)
When commencing Rasagiline Mesilate, the patient experienced the following unwanted symptoms/side effects:
  • Parkinson^s Disease
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as parkinson^s disease, may become evident only after a product is in use by the general population.

Parkinson's Disease
This is a report of a male patient (weight: NA) from CHINA. The patient developed the following symptoms/conditions: parkinson's disease and was treated with Rasagiline Mesylate (dosage: NA) starting Oct 21, 2011. Concurrently used drugs:
  • Sinemet (1st Dose)
  • Sinemet (3rd Dose)
  • Sinemet (1st Dose)
  • Entacapone (200 Milligram;)
  • Piribedil Sustained Release Tablets (150 Milligram;)
  • Madopar (1st Dose)
  • Sinemet (2nd Dose)
Soon after that, the consumer experienced the following side effects:
  • Parkinson's Disease
The patient was hospitalized. This opens a possibility that Rasagiline Mesylate treatment could cause the above reactions, including parkinson's disease, and some male subjects may be more susceptible.


Pharyngeal Cancer
A 62-year-old male patient (weight: NA) from AR with the following symptoms/conditions: parkinson^s disease started Rasagiline Mesilate treatment (dosage: 1 Milligram Daily; Ol- Adagio Fu, 1mg/day) on Apr 19, 2011. Soon after starting Rasagiline Mesilate treatment, the subject experienced various side effects, including:
  • Pharyngeal Cancer
Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Rasagiline Mesilate.

Jealous Delusion, Marital Problem
A 61-year-old male patient from SPAIN (weight: NA) experienced symptoms, such as: parkinson's disease and was treated with Rasagiline(dosage: 1 Mg). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Jealous Delusion
  • Marital Problem
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Rasagiline efficacy:
  • Pramipexole Dihydrochloride (2.1 Mg)


Laryngeal Cancer
In this report, Rasagiline Mesylate was administered for the following condition: parkinson's disease.A male consumer from ARGENTINA (weight: NA) started Rasagiline Mesylate treatment (dosage: 1 Milligram; Ol- Adagio Fu, 1mg/day) on Aug 17, 2006.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Laryngeal Cancer
A possible interaction with other drugs could have contributed to this reaction:
  • Carbidopa + Levodopa (100/25 Bid)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Rasagiline Mesylate treatment could be related to the listed above side effect(s).

Serotonin Syndrome, Neuroleptic Malignant Syndrome
This is a report of the following Rasagiline side effect(s):
  • Serotonin Syndrome
  • Neuroleptic Malignant Syndrome
A 81-year-old male patient from DENMARK (weight: NA) presented with the following condition: parkinson's disease and received a treatment with Rasagiline (dosage: NA) starting: Oct 01, 2009.The following concurrently used drugs could have generated interactions:
  • Finasteride (finasteride)(finasteride)
  • Omeprazole
  • Stalevo (stalevo) (stalevo)
  • Dalteparin (dalteparin) (dalteparin)
  • Calcium W/colecalciferol(calcium, Colecalciferol)(calcium, Colecalcife
  • Alendronic Acid (alendronic Acid)(alendronic Acid)
  • Citalopram Hydrobromide
  • Midodrine (midodrine) (midodrine)
The patient was hospitalized.This report suggests that a Rasagiline treatment could be associated with the listed above side effect(s).

Quality Of Life Decreased, Confusional State, Cognitive Disorder, Activities Of Daily Living Impaired, Apathy
This Rasagiline report was submitted by a 72-year-old male consumer from BRAZIL (weight: NA). The patient was diagnosed with: NA and Rasagiline was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Quality Of Life Decreased
  • Confusional State
  • Cognitive Disorder
  • Activities Of Daily Living Impaired
  • Apathy
Other drugs used simultaneously:
  • Domperidone (30 Mg/daily)
  • Benserazide Hydrochloride W/levodopa (100/25 Mg)
  • Entacapone (200 Mg/day)
  • Enablex (7.5 Mg, Unk)
  • Lactulose
  • Rivastigmine (2 Mg, Tid)
  • Amantadine Hcl (300 Mg/day)
  • Tolcapone (300 Mg/day)
Those unexpected symptoms could be linked to a Rasagiline treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Squamous Cell Carcinoma
This is a report of a possible correlation between Rasagiline Mesylate use and the following symptoms/side effect(s):
  • Squamous Cell Carcinoma
which could contribute to an assessment of Rasagiline Mesylate risk profile.A male consumer from ARGENTINA (weight: NA) was suffering from parkinson's disease and was treated with Rasagiline Mesylate (dosage: 1 Milligram; Ol- Adagio Fu, 1mg/day) starting Apr 24, 2007.Other concurrent medications: NA.

Squamous Cell Carcinoma
A male patient from ARGENTINA (weight: NA) presented with the following symptoms: parkinson's disease and after a treatment with Rasagiline Mesylate (dosage: 1 Milligram; Ol- Adagio Fu, 1mg/day) experienced the following side effect(s):
  • Squamous Cell Carcinoma
The treatment was started on Apr 24, 2007. Rasagiline Mesylate was used in combination with the following drugs:
  • Carbidopa + Levodopa (100/25 Bid)
This report could alert potential Rasagiline Mesylate consumers.

Hyperpyrexia, Muscle Rigidity, Neuroleptic Malignant Syndrome, Hypertonia, Serotonin Syndrome, Hyperhidrosis, Blood Creatine Phosphokinase Increased
In this report, a 81-year-old male patient from (weight: NA) was affected by a possible Rasagiline side effect.The patient was diagnosed with parkinson's disease. After a treatment with Rasagiline (dosage: 1 Mg (1 Mg,1 In 1 D),oral, start date: Oct 01, 2009), the patient experienced the following side effect(s):
  • Hyperpyrexia
  • Muscle Rigidity
  • Neuroleptic Malignant Syndrome
  • Hypertonia
  • Serotonin Syndrome
  • Hyperhidrosis
  • Blood Creatine Phosphokinase Increased
The following simultaneously used drugs could have led to this reaction:
  • Midodrine Hydrochloride
  • Piperacillin And Tazobactam (pip/tazo)
  • Stalevo 100
  • Alendronate Sodium
  • Finasteride
  • Citalopram Hydrobromide (10 Mg (10 Mg,1 In 1 D),oral)
  • Calcium And Colecalciferol (lekovit Ca)
  • Omeprazole
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Rasagiline treatment.

Aggression, Paranoia, Suicidal Ideation, Euphoric Mood, Excessive Exercise, Voyeurism, Panic Attack, Sudden Onset Of Sleep, Delusion
This is a report of a 65-year-old male patient from (weight: NA), who used Rasagiline Mesylate (rasagiline) (dosage: NA) for a treatment of NA. After starting a treatment on Aug 28, 2008, the patient experienced the following side effect(s):
  • Aggression
  • Paranoia
  • Suicidal Ideation
  • Euphoric Mood
  • Excessive Exercise
  • Voyeurism
  • Panic Attack
  • Sudden Onset Of Sleep
  • Delusion
The following drugs could possibly have interacted with the Rasagiline Mesylate (rasagiline) treatment
  • Ropinirole (750 Micrograms, 3 In 1 D, Oral Use)
  • Requip Xl (36 Milligram, 1 In 1 D, Oral Use)
  • Co-careldopa (carbidopa, Levodopa) (carbidopa, Levodopa)
  • Sinemet (carbidopa, Carbidopa Monohydrate, Levodopa) (carbidopa, Carbi
The patient was hospitalized and became disabled.Taken together, these observations suggest that a Rasagiline Mesylate (rasagiline) treatment could be related to side effect(s), such as Aggression, Paranoia, Suicidal Ideation, Euphoric Mood, Excessive Exercise, Voyeurism, Panic Attack, Sudden Onset Of Sleep, Delusion.

Feeling Drunk, Tremor
This feeling drunk side effect was reported by a consumer or non-health professional from UNITED STATES. A male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Rasagiline (dosage: 1 Mg, 1x/day), which was started on Jul 30, 2011. Concurrently used drugs:
  • Neurontin (300 Mg, 3x/day)
  • Neurontin
  • Dyazide (Unk)
  • Neurontin
When starting to take Rasagiline the consumer reported the following symptoms:
  • Feeling Drunk
  • Tremor
These side effects may potentially be related to Rasagiline.

Obsessive Thoughts, Aggression, Dementia, Obsessive-compulsive Disorder, Libido Increased, Impulse-control Disorder, Excessive Sexual Fantasies, Personality Change, Withdrawal Syndrome
This is a Rasagiline Mesylate side effect report of a 67-year-old male patient (weight:NA) from UNITED KINGDOM, suffering from the following symptoms/conditions: NA, who was treated with Rasagiline Mesylate (dosage:NA, start time: Jan 01, 2008), combined with:
  • Sinemet
  • Ropinirole
  • Requip Xl
, and developed a serious reaction and a obsessive thoughts side effect. The patient presented with:
  • Obsessive Thoughts
  • Aggression
  • Dementia
  • Obsessive-compulsive Disorder
  • Libido Increased
  • Impulse-control Disorder
  • Excessive Sexual Fantasies
  • Personality Change
  • Withdrawal Syndrome
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Rasagiline Mesylate treatment in male patients suffering from NA, resulting in obsessive thoughts.

Anaemia, Asthenia, Folate Deficiency, Gastritis Atrophic, Macrocytosis, Oedema Peripheral, Vitamin B12 Deficiency
This report suggests a potential Rasagiline Mesylate anaemia side effect(s) that can have serious consequences. A male patient from ARGENTINA (weight:NA) was diagnosed with the following health condition(s): parkinson's disease and used Rasagiline Mesylate (dosage: NA) starting Jul 16, 2010. Soon after starting Rasagiline Mesylate the patient began experiencing various side effects, including:
  • Anaemia
  • Asthenia
  • Folate Deficiency
  • Gastritis Atrophic
  • Macrocytosis
  • Oedema Peripheral
  • Vitamin B12 Deficiency
Drugs used concurrently:NA. The patient was hospitalized. Although Rasagiline Mesylate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as anaemia, may still occur.

Anaemia, Asthenia, Oedema Peripheral
This anaemia problem was reported by a physician from ARGENTINA. A male patient (weight: NA) was diagnosed with the following medical condition(s): parkinson's disease.On Jul 16, 2010 a consumer started treatment with Rasagiline Mesylate (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Rasagiline Mesylate, the patient experienced the following unwanted symptoms /side effects:
  • Anaemia
  • Asthenia
  • Oedema Peripheral
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as anaemia, may become evident only after a product is in use by the general population.

Anaemia, Asthenia, Oedema Peripheral
This is a Rasagiline Mesylate side effect report of a male patient (weight: NA) from ARGENTINA. The patient developed the following symptoms/conditions: parkinson's disease and was treated with Rasagiline Mesylate (dosage: NA) starting Jul 16, 2010. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Anaemia
  • Asthenia
  • Oedema Peripheral
The patient was hospitalized. This opens a possibility that Rasagiline Mesylate could cause anaemia and that some male patients may be more susceptible.

Anaemia, Asthenia, Oedema Peripheral
A male patient (weight: NA) from ARGENTINA with the following symptoms: parkinson's disease started Rasagiline Mesylate treatment (dosage: NA) on Jul 16, 2010. Soon after starting Rasagiline Mesylate treatment, the consumer experienced several side effects, including:
  • Anaemia
  • Asthenia
  • Oedema Peripheral
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Rasagiline Mesylate side effects, such as anaemia.

Convulsion, Hypersensitivity
This convulsion side effect was reported by a pharmacist from UNITED STATES. A 42-year-old female patient (weight:NA) experienced the following symptoms/conditions: parkinson's disease.The patient was prescribed Rasagiline (dosage: 1mg Daily Po), which was started on Jan 01, 2007. Concurrently used drugs: NA..When starting to take Rasagiline the consumer reported symptoms, such as:
  • Convulsion
  • Hypersensitivity
These side effects may potentially be related to Rasagiline. The patient was hospitalized.

Tardive Dyskinesia
This is a report of a 64-year-old male patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Rasagiline (dosage: Po, start time: Apr 22, 2008), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Tardive Dyskinesia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Rasagiline treatment in male patients, resulting in tardive dyskinesia side effect.

Confusional State, Hallucination, Visual
This report suggests a potential Rasagiline Confusional State, Hallucination, Visual side effect(s) that can have serious consequences. A 66-year-old female patient (weight: NA) from SPAIN was diagnosed with the following symptoms/conditions: parkinson's disease,depression and used Rasagiline (dosage: 1 Mg/day) starting NS. Soon after starting Rasagiline the patient began experiencing various side effects, including:
  • Confusional State
  • Hallucination, Visual
Drugs used concurrently:
  • Escitalopram (10 Mg/day)
The patient was hospitalized. Although Rasagiline demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as confusional state, may still occur.

Diarrhoea, Nausea, Vomiting
This Diarrhoea, Nausea, Vomiting problem was reported by a pharmacist from UNITED STATES. A 63-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: parkinson's disease. On Nov 28, 2006 this consumer started treatment with Rasagiline (dosage: 1 Mg Every Day Po). The following drugs were being taken at the same time:
  • Carbidopa And Levodopa (50/200 Mg Bid Po)
When commencing Rasagiline, the patient experienced the following unwanted symptoms/side effects:
  • Diarrhoea
  • Nausea
  • Vomiting
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as diarrhoea, may become evident only after a product is in use by the general population.

Blood Pressure Inadequately Controlled, Hypertension
This is a report of a 79-year-old male patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: parkinson's disease and was treated with Rasagiline (dosage: 1 Mg Every Day Po) starting Dec 12, 2006. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Blood Pressure Inadequately Controlled
  • Hypertension
This opens a possibility that Rasagiline treatment could cause the above reactions, including blood pressure inadequately controlled, and some male subjects may be more susceptible.

Myocardial Infarction
A female patient (weight: NA) from SOUTH AFRICA with the following symptoms/conditions: parkinson's disease started Rasagiline Mesilate treatment (dosage: NA) on Sep 01, 2008. Soon after starting Rasagiline Mesilate treatment, the subject experienced various side effects, including:
  • Myocardial Infarction
Concurrently used drugs:
  • Sinemet (100/25)
  • Bromocriptine
  • Amantadine Hcl
  • Metformin Hcl
  • Amlodipine
  • Enalapril Maleate
This finding indicates that some female patients could be more vulnerable to Rasagiline Mesilate.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Rasagiline Side Effects

    Did You Have a Rasagiline Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Rasagiline for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Rasagiline Safety Alerts, Active Ingredients, Usage Information

    More About Rasagiline

    Side Effects reported to FDA: 26

    Rasagiline safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 6

    Latest Rasagiline clinical trials

    Rasagiline Reviews

    No reviews, be a first to report a side effect via side effect reporting form